- Oral Abstract Session - Immunotherapy
- Poster Discussion Session - Immunotherapy
- Rapid Abstract Session - Immunotherapy
- Traversing Toxicities of Immuno-Oncology Agents - Molecular Predictors and Rational Outcomes
- The Promise of Neoadjuvant Immunotherapy Across Solid Tumors
- Oral Abstract Session - Developmental Therapeutics - Molecularly Targeted Agents and Tumor Biology
- Poster Discussion Session - Developmental Therapeutics - Molecularly Targeted Agents and Tumor Biology
Oral Abstract Session - Immunotherapy
Initial results from the phase 2A trial of visugromab (CTL-002) + nivolumab in advanced/metastatic anti-PD1/-L1 relapsed/refractory solid tumors (The GDFATHER-TRIAL).
Abstract: 2501: Ignacio Melero Bermejo, Maria J. de Miguel, Guzman Alonso, et al.
Presenter: IGNACIO MELERO BERMEJO
Zusammenfassung folgt
--------------------------------------------------------------------------------------------------------------------------
Initial results from a first-in-human, phase I study of immunomodulatory aryl hydrocarbon receptor (AhR) inhibitor BAY2416964 in patients with advanced solid tumors.
Abstract: 2502: Ecaterina Dumbrava, Michael Cecchini, Jon Zugazagoitia, et al.
Presenter: Ecaterina Elena Dumbrava MD
Zusammenfassung folgt
--------------------------------------------------------------------------------------------------------------------------
Tumor mutational burden (TMB) measurement from an FDA-approved assay and real-world overall survival (rwOS) on single-agent immune checkpoint inhibitors (ICI) in over 8,000 patients across 24 cancer types.
Abstract: 2503:David Gandara, Neeraj Agarwal, Shilpa Gupta, et al.
Presenter: David R. Gandara, MD, FASCO
Zusammenfassung folgt
--------------------------------------------------------------------------------------------------------------------------
Evaluation of change in RECIST tumor size and survival in patients with rare cancers treated with checkpoint inhibitor therapy (SWOG S1609).
Abstract: 2504: Megan Othus, Sandip Patel, Young Kwang Chae, et al.
Presenter: Megan Othus
Zusammenfassung folgt
--------------------------------------------------------------------------------------------------------------------------
Interim update of the ATRC-101 phase 1b trial in advanced solid tumors.
Abstract: 2505: Bartosz Chmielowski, Saravut Weroha, Susanna Ulahannan, et al.
Presenter: Bartosz Chmielowski, MD, PhD
Zusammenfassung folgt
--------------------------------------------------------------------------------------------------------------------------
Phase I study of the bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 combined with SHR2554, an EZH2 inhibitor, in patients with previously treated advanced lymphoma and solid tumors.
Abstract: 2507: Kaichao Feng, Yang Liu, Chunmeng Wang, et al.
Presenter: Kaichao Feng
Zusammenfassung folgt
--------------------------------------------------------------------------------------------------------------------------
Phase 1/2 Study of DF1001, a novel tri-specific, NK cell engager therapy targeting HER2, in patients with advanced solid tumors: Phase 1 DF1001 monotherapy dose-escalation results.
Abstract: 2508: Howard Safran, Philippe Cassier, Cecile Vicier, et al.
Presenter: Howard Safran MD
Zusammenfassung folgt
--------------------------------------------------------------------------------------------------------------------------
To watch the Presentation and Discussion of this Oral Abstract Session, you need an ASCO Annual Meeting registration.
--------------------------------------------------------------------------------------------------------------------------
POSTER SESSION:
Poster Discussion Session - Immunotherapy
Abstract: 2517 | Poster Bd #: 359: Frederick Locke, Lazaros Lekakis, Herbert Eradat, et al.
Presenter: Frederick L. Locke MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 2518 | Poster Bd #: 360: Andreas Mackensen, John Haanen, Christian Koenecke, et al.
Presenter: Andreas Mackensen, MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 2519 | Poster Bd #: 361: Benjamin Schlechter, Daniel Olson, Mridula George, et al.
Presenter: Benjamin L. Schlechter, MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 2520 | Poster Bd #: 362: Dongmei Ji, Yao Weitao, Xiangmin Tong, et al.
Presenter: Dongmei Ji MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 2521 | Poster Bd #: 363:Kamaneh Montazeri, Diwakar Davar, Cara Haymaker, et al.
Presenter: Kamaneh Montazeri MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 2522 | Poster Bd #: 364: Mairi Lucas, Zak Kinsella, Claudia Gonzalez, et al.
Presenter: Mairi Lucas MBChB
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 2523 | Poster Bd #: 365: Ira Winer, Amita Patnaik, Minal Barve, et al.
Presenter: Ira Seth Winer MD, PhD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 2524 | Poster Bd #: 366: Minal Barve, Anthony Tolcher, Richard Carvajal, et al.
Presenter: Minal A. Barve MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 2525 | Poster Bd #: 367: Adil Daud, Costantine Albany, Vamsidhar Velcheti, et al.
Presenter: Adil Daud
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 2526 | Poster Bd #: 368: Pei Shu, Xiaoyu Li, Li Yuan, Qi Zhou, et al.
Presenter: Pei Shu
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
A phase 1 dose-escalation study of RiMO-301 with palliative radiation in advanced tumors.
Abstract: 2527 | Poster Bd #: 369: Matthew Koshy, Michael Spiotto, Lawrence Feldman, et al.
Presenter: Matthew Koshy MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 2528 | Poster Bd #: 370: Eileen O'Reilly, Zev Wainberg, Colin Weekes, et al.
Presenter: Eileen Mary O'Reilly, MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
To watch the Presentation and Discussion of this Poster Discussion Session, you need an ASCO Annual Meeting registration.
Rapid Abstract Session - Immunotherapy
Abstract: 2512 :
Presenter: Delvys Rodriguez-Abreu, MD, PhD
----------------------------------------------------------------------------------------------------------------------
Targeting CD47 in lymphoid malignancies with CAR T cells.
Abstract: 2513 :
Presenter:Alexander Paul Boardman
----------------------------------------------------------------------------------------------------------------------
Abstract: 2514 :
Presenter: Megan Babette Barnet, PhD, BS, MBBS, FRACP
----------------------------------------------------------------------------------------------------------------------
Intestinal microbiome characterization in immune checkpoint inhibition (ICI) resistant disease.
Abstract: 2515 :
Presenter: Pavlina Spiliopoulou, MD, PhD
----------------------------------------------------------------------------------------------------------------------
Abstract: 2516:
Presenter: Filippo Gustavo Dall’Olio MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
To watch the Presentation and Discussion of this Rapid Abstract Session, you need an ASCO Annual Meeting registration.
Clinical Science Symposium: Traversing Toxicities of Immuno-Oncology Agents: Molecular Predictors and Rational Outcomes
Abstract: 2509:
Presenter: Karina Ruiz-Esteves
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
First-line treatment of fecal microbiota transplantation for immune-mediated colitis.
Abstract: 2510:
Presenter: Yinghong Wang
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 2511:
Presenter: Bilal Ahmed Siddiqui MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
To watch the Presentation and Discussion of this Clinical Science Symposium, you need an ASCO Annual Meeting registration.
Clinical Science Symposium: The Promise of Neoadjuvant Immunotherapy Across Solid Tumors
Abstract: LBA10:
Presenter: Heather A. Wakelee, MD, FASCO
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 10:
Presenter: Irene L.M. Reijers MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 10:
Presenter: Denise Wolf
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Friendly-user score assessing gut dysbiosis and resistance to immune checkpoint inhibitors (ICI).
Abstract: 103:
Presenter: Lisa Derosa MD, PhD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
To watch the Presentation and Discussion of this Clinical Science Symposium, you need an ASCO Annual Meeting registration.
Oral Abstract Session - Molecularly Targeted Agents and Tumor Biology
Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) interim results.
Abstract: LBA3000: Funda Meric-Bernstam, Vicky Makker, Ana Oaknin, et al.
Presenter: Funda Meric-Bernstam, MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic solid tumor: Results from a first-in-human phase 1 study.
Abstract: 3001: Li Zhang, Yuxiang Ma, Yuangyuan Zhao, et al.
Presenter: Li Zhang, MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
First-in-human study of ABBV-011, a seizure-related homolog protein 6 (SEZ6)–targeting antibody-drug conjugate, in patients with small cell lung cancer.
Abstract: 3002: Daniel Morgensztern, Neal Ready, Melissa Johnson, et al.
Presenter: Daniel Morgensztern MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Detection of peritoneal metastases during cytoreductive surgery using pegsitacianine, a pH sensitive imaging agent: Final results from a phase 2 study.
Abstract: 3003: Patrick Wagner, Edward Levine, Alex Kim, et al.
Presenter: Patrick Wagner, MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Methylated DNA biomarkers and incident cancer in the American Cancer Society (ACS) Cancer Prevention Study-3 (CPS-3) cohort.
Abstract: 3004: Alpa Patel, Christina Clarke Dur, Gregory Alexander, et al.
Presenter: Alpa Patel PhD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Tumor fraction to improve patient selection for oncology early phase clinical trials: Analysis of two precision medicine studies.
Abstract: 3005: Sophie Cousin, Laila Belcaid, Kilian Trin, et al.
Presenter: Sophie Cousin
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Safety and efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid and CNS tumors: Results from a phase 1/2a study.
Abstract: 3006: Macarena De La Fuente, Jordi Rodon Ahnert, Rona Yaeger, et al
Presenter: Macarena Ines De La Fuente, MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
A phase I study of KL590586, a next-generation selective RET inhibitor, in patients with RET-altered solid tumors.
Abstract: 3007: Qing Zhou, Yi-Long Wu, Xiangqian Zheng, et al
Presenter: Qing Zhou
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
A phase 1 study of the protein arginine methyltransferase 5 (PRMT5) brain-penetrant inhibitor PRT811 in patients (pts) with recurrent high-grade glioma or uveal melanoma (UM).
Abstract: 3008: Varun Monga, Tanner Johanns, Roger Stupp, et al
Presenter: Varun Monga MBBS
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
To watch the Presentation and Discussion of this Poster Discussion Session, you need an ASCO Annual Meeting registration.
------------------------------------------------------------------------------------------------------------------
POSTER SESSION:
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Poster Discussion Session - Molecularly Targeted Agents and Tumor Biology Primary
Abstract: 3009 | Poster Bd #: 207: Timothy Yap, Antonio Giordano, Erika Hamilton, et al.
Presenter: Timothy A. Yap MD, PhD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 3010 | Poster Bd #: 208: Timothy Yap, Abdelaziz Elhaddad, Rachel Grisham, et al.
Presenter: Timothy A. Yap MD, PhD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 3011 | Poster Bd #: 209: Shao Zhimin, Lei Fan, Ma Linxiaoxi, et al.
Presenter: Shao Zhimin, MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 3012 | Poster Bd #: 210: Hans Gelderblom, Mathilde Jalving, Ingrid Desar, et al.
Presenter: Hans Gelderblom MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 3014 | Poster Bd #: 212: Hiroya Taniguchi, Masataka Yagisawa, Taroh Satoh, et al.
Presenter: Hiroya Taniguchi, MD, PhD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 3015 | Poster Bd #: 213: Manish Sharma, Yasutoshi Kuboki, D. Camidge, et al.
Presenter: Manish Sharma MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 3016 | Poster Bd #: 214: Yakun Wang, Jifang Gong, Rongbo Lin, et al.
Presenter: Yakun Wang, PhD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 3017 | Poster Bd #: 215: Jie Wang, Jianchun Duan, Ligang Xing, et al.
Presenter: Jianchun Duan
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 3018 | Poster Bd #: 216: Apostolia Tsimberidou, David Vining, Sukeshi Arora, et al.
Presenter: Apostolia Maria Tsimberidou MD, PhD, FASCO
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 3019 | Poster Bd #: 217: Sarina Piha-Paul, Sanjay Goel, Chih-Yi Liao, et al.
Presenter: Milind M. Javle MD
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
Abstract: 3020 | Poster Bd #: 218: Alexander Drilon, Melissa Johnson, Shirish Gadgeel, et al.
Presenter: Alexander E. Drilon
Zusammenfassung folgt
----------------------------------------------------------------------------------------------------------------------
To watch the Presentation and Discussion of this Poster Discussion Session, you need an ASCO Annual Meeting registration.